Welcome : Guest

Cormedix, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Cormedix, Inc., which is principally involved in Prophylactic and Therapeutic Products Business. Illustrated with 18 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64135
Price: $900
Company Type: Public
Pages: 20
Date: November 2016
Market Data Tables: 18

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Antibiotics......3
Table 1: Antibiotics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......3
Table 2: Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Tygacil, Vancocin (Generic), Vibativ (Telavancin), and Zyvox......4
Table 3: Antibiotics Market by Category in China (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......5
Table 4: Antibiotic Market by Drug Type in the US (2015) - Percentage Share Breakdown by Podiatrists Prescription for Cephalosporins, Macrolides, Penicillins, Quinolones, and Tetracyclines......6
Antiviral......7
Table 5: Antiviral Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antiviral Drugs, Monoclonal Antibodies, Vaccines and Others......7
Infectious Disease Drugs......8
Table 6: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......8
Table 7: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......9
Anticoagulants......10
Table 8: Coagulation Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Hemaphillia A, Hemaphillia B, Inhibitor Bleed Treatment, and Von Willebrand Disease (VWD)......10
Table 9: Anticoagulant Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Heparin, Low-Molecular-Weight Heparin (LMWH), Novel Oral Anticoagulants, Warfarin, and Other Injectable Anticoagulants......11
Table 10: Anticoagulation Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Direct Thrombin Inhibitors (DTI), Low-Molecular-Weight Heparin (LMWH), Unfractionated Heparin (UFH), Vitamin K Antagonists (VKA) and Others......12
Table 11: Anticoagulation Therapy by Segment Worldwide (2015) - Percentage Market Share Breakdown by Value for Acute Coronary Syndrome and Myocardial Infarction, Prevention of Venous Thromboembolism, Stroke Prevention in Atrial Fibrillation, Venous Thromboembolism Treatment and Other Primary Prevention......13
Central Venous Catheter (CVC)......14
Table 12: Vascular Access Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Arterial, Central Venous Catheter (CVC), Peripherally Inserted Central Catheter (PICC), and Vascular Positioning System (VPS)......14
Antibiotics......15
Table 13: Branded Acute Bacterial Skin and Skin Structure Infection Antibiotic Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Cubicin (Daptomycin), Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......15
Table 14: Branded Community-Acquired Bacterial Pneumonia Antibiotic Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......16
Anti-Infectives......17
Table 15: Market Shares of Leading Anti-Infective Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Vétoquinol S.A., Virbac S.A., Zoetis, Inc. and Others......17
Infectious Disease Drugs......18
Table 16: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......18
Catheters (Central Venous (CVC))......19
Table 17: Market Shares of Leading Central Venous Catheter (CVC) Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Braun GmbH, Edwards Lifesciences Corporation, Teleflex Incorporated, Vygon SA, and Others......19
Table 18: Market Shares of Leading Central Venous Catheter Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Braun AG, Edwards Lifesciences Corporation, Teleflex Incorporated (Arrow International Inc), Vygon (UK), Ltd., and Others......20